Perspectives from our team on detecting under-recognized disease from routine echocardiograms — and on the clinical evidence and reimbursement that let health systems act on it.
Clinical Education
The Amyloid Heart: What Cardiac Amyloidosis Is and How to Diagnose It
A short visual primer on cardiac amyloidosis — what it is, why it hides on routine echoes, the clues that raise suspicion, and the non-invasive work-up that confirms it. With a three-minute illustrated summary and the full study at identifyamyloid.com.
David Ouyang, MD · October 2026 · 6 min read
Reimbursement
Deployment, CPT 0932T, and Getting Reimbursed with Precision Cardiac Amyloid
The outpatient AI echo code, CPT 0932T, has been active since January 1, 2025. What the descriptor actually says, the clinical evidence behind it, and how to report it for InVision Precision Cardiac Amyloid.
Bryan He · October 2026 · 7 min read
Reimbursement
Medicare's New NTAP for AI Cardiac Amyloidosis Detection: What It Means for Inpatient Deployment
CMS has approved a New Technology Add-on Payment for InVision Precision Cardiac Amyloid, effective October 1, 2026 — up to $2,275 per eligible inpatient stay. What the final rule says, how the add-on is calculated, and what it means for inpatient deployment.
Bryan He, PhD · August 2026 · 8 min read
We use cookies for analytics to understand and improve how this site is used.
You can accept or decline analytics cookies. See our Privacy Policy.